Cargando…
Mangiferin Decreases Plasma Free Fatty Acids through Promoting Its Catabolism in Liver by Activation of AMPK
Mangiferin has been shown to have the effect of improving dyslipidemia. Plasma free fatty acids (FFA) are closely associated with blood lipid metabolism as well as many diseases including metabolic syndrome. This study is to investigate whether mangiferin has effects on FFA metabolism in hyperlipide...
Autores principales: | Niu, Yucun, Li, Songtao, Na, Lixin, Feng, Rennan, Liu, Liyan, Li, Ying, Sun, Changhao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3264633/ https://www.ncbi.nlm.nih.gov/pubmed/22292039 http://dx.doi.org/10.1371/journal.pone.0030782 |
Ejemplares similares
-
Mangiferin supplementation improves serum lipid profiles in overweight patients with hyperlipidemia: a double-blind randomized controlled trial
por: Na, Lixin, et al.
Publicado: (2015) -
Mangiferin Improved Palmitate-Induced-Insulin Resistance by Promoting Free Fatty Acid Metabolism in HepG2 and C2C12 Cells via PPARα: Mangiferin Improved Insulin Resistance
por: Zhang, Qiao, et al.
Publicado: (2019) -
Free fatty acids profile among lean, overweight and obese non-alcoholic fatty liver disease patients: a case – control study
por: Feng, Rennan, et al.
Publicado: (2017) -
Mangiferin for the Management of Liver Diseases: A Review
por: Li, Lisi, et al.
Publicado: (2023) -
Sterol Regulatory Element–Binding Protein-1c Mediates Increase of Postprandial Stearic Acid, a Potential Target for Improving Insulin Resistance, in Hyperlipidemia
por: Chu, Xia, et al.
Publicado: (2013)